155 related articles for article (PubMed ID: 34106301)
1. LI-RADS treatment response lexicon: review, refresh and resolve with emerging data.
Ram R; Kampalath R; Shenoy-Bhangle AS; Arora S; Kielar AZ; Mendiratta-Lala M
Abdom Radiol (NY); 2021 Aug; 46(8):3549-3557. PubMed ID: 34106301
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
Bae JS; Lee JM; Yoon JH; Kang HJ; Jeon SK; Joo I; Lee KB; Kim H
Radiology; 2021 May; 299(2):336-345. PubMed ID: 33650901
[TBL] [Abstract][Full Text] [Related]
3. Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS Treatment Response Assessment Criteria.
Bajaj G; Sundaram K; Jambhekar K; Ram R
Semin Ultrasound CT MR; 2021 Aug; 42(4):318-331. PubMed ID: 34130846
[TBL] [Abstract][Full Text] [Related]
4. LI-RADS: Past, Present, and Future, From the
Marks RM; Masch WR; Chernyak V
AJR Am J Roentgenol; 2021 Feb; 216(2):295-304. PubMed ID: 33052720
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence in assessment of hepatocellular carcinoma treatment response.
Spieler B; Sabottke C; Moawad AW; Gabr AM; Bashir MR; Do RKG; Yaghmai V; Rozenberg R; Gerena M; Yacoub J; Elsayes KM
Abdom Radiol (NY); 2021 Aug; 46(8):3660-3671. PubMed ID: 33786653
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Hepatocellular Carcinoma Treatment Response After Locoregional Therapy.
Kampalath R; Tran-Harding K; Do RKG; Mendiratta-Lala M; Yaghmai V
Magn Reson Imaging Clin N Am; 2021 Aug; 29(3):389-403. PubMed ID: 34243925
[TBL] [Abstract][Full Text] [Related]
7. Imaging After Locoregional Therapy for Hepatocellular Carcinoma With Emphasis on LIRADS Treatment Response Assessment Criteria.
Bajaj G; Sundaram K; Jambhekar K; Ram R
Semin Ultrasound CT MR; 2021 Aug; 42(4):390-404. PubMed ID: 34130851
[TBL] [Abstract][Full Text] [Related]
8. Liver imaging: it is time to adopt standardized terminology.
Chernyak V; Tang A; Do RKG; Kamaya A; Kono Y; Santillan CS; Fowler KJ; Bashir MR; Cunha GM; Fetzer DT; Kielar A; Lee JT; Mendiratta-Lalla M; Sirlin CB;
Eur Radiol; 2022 Sep; 32(9):6291-6301. PubMed ID: 35389052
[TBL] [Abstract][Full Text] [Related]
9. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.
Kielar A; Fowler KJ; Lewis S; Yaghmai V; Miller FH; Yarmohammadi H; Kim C; Chernyak V; Yokoo T; Meyer J; Newton I; Do RK
Abdom Radiol (NY); 2018 Jan; 43(1):218-230. PubMed ID: 28780679
[TBL] [Abstract][Full Text] [Related]
10. LI-RADS
Chernyak V; Santillan CS; Papadatos D; Sirlin CB
Abdom Radiol (NY); 2018 Jan; 43(1):111-126. PubMed ID: 28695233
[TBL] [Abstract][Full Text] [Related]
11. Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm.
An C; Rakhmonova G; Choi JY; Kim MJ
Clin Mol Hepatol; 2016 Jun; 22(2):296-307. PubMed ID: 27304548
[TBL] [Abstract][Full Text] [Related]
12. Imaging Diagnosis of Hepatocellular Carcinoma: The Liver Imaging Reporting and Data System, Why and How?
Cunha GM; Fowler KJ; Abushamat F; Sirlin CB; Kono Y
Clin Liver Dis; 2020 Nov; 24(4):623-636. PubMed ID: 33012449
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.
Seo N; Kim MS; Park MS; Choi JY; Do RKG; Han K; Kim MJ
Eur Radiol; 2020 Jan; 30(1):261-271. PubMed ID: 31418085
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF
Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016
[TBL] [Abstract][Full Text] [Related]
15. LI-RADS 2017: An update.
Kielar AZ; Chernyak V; Bashir MR; Do RK; Fowler KJ; Mitchell DG; Cerny M; Elsayes KM; Santillan C; Kamaya A; Kono Y; Sirlin CB; Tang A
J Magn Reson Imaging; 2018 Jun; 47(6):1459-1474. PubMed ID: 29626376
[TBL] [Abstract][Full Text] [Related]
16. Multimodality Imaging of Hepatocellular Carcinoma: From Diagnosis to Treatment Response Assessment in Everyday Clinical Practice.
Delli Pizzi A; Mastrodicasa D; Cianci R; Serafini FL; Mincuzzi E; Di Fabio F; Giammarino A; Mannetta G; Basilico R; Caulo M
Can Assoc Radiol J; 2021 Nov; 72(4):714-727. PubMed ID: 32436394
[TBL] [Abstract][Full Text] [Related]
17. Imaging diagnosis of hepatocellular carcinoma: LI-RADS.
Cunha GM; Sirlin CB; Fowler KJ
Chin Clin Oncol; 2021 Feb; 10(1):3. PubMed ID: 32527115
[TBL] [Abstract][Full Text] [Related]
18. LI-RADS Version 2018 Treatment Response Algorithm: Diagnostic Performance after Transarterial Radioembolization for Hepatocellular Carcinoma.
Yoon J; Lee S; Shin J; Kim SS; Kim GM; Won JY
Korean J Radiol; 2021 Aug; 22(8):1279-1288. PubMed ID: 33987991
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of Ancillary MRI Features Into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment of Hepatocellular Carcinoma.
Kim YY; Kim MJ; Yoon JK; Shin J; Roh YH
AJR Am J Roentgenol; 2022 Mar; 218(3):484-493. PubMed ID: 34585608
[No Abstract] [Full Text] [Related]
20. Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents.
Aslam A; Kamath A; Spieler B; Maschiocchi M; Sabottke CF; Chernyak V; Lewis SC
Abdom Radiol (NY); 2021 Aug; 46(8):3565-3578. PubMed ID: 33856509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]